Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2001 Dec 1;33(11):1865-70. Epub 2001 Oct 25.

Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.

Author information

1
Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA. rbt2n@virginia.edu

Abstract

Zinc has generally been administered by the oral route in studies of prevention or treatment of the common cold. The purpose of these studies was to evaluate the effectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus infection and illness. Ninety-one volunteers, 41 treated with active medication and 50 treated with placebo, received study medication for 3 days, were inoculated with rhinovirus, and then were treated with study medication for an additional 6 days. Rhinovirus infection was documented in 37 (74%) of the 50 placebo-treated volunteers and in 32 (78%) of the 41 volunteers treated with active medication. Zinc treatment had no effect on total symptom score, rhinorrhea, nasal obstruction, or the proportion of infected volunteers who developed clinical colds. These data do not support a role for intranasal zinc gluconate for prevention or treatment of the common cold.

PMID:
11692298
DOI:
10.1086/324347
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center